Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Akira, Horikoshi"'
Autor:
Atsushi Tanide, Shohei Nakamura, Akira Horikoshi, Shigeru Takatsuji, Takahiro Kimura, Kazuo Kinose, Soichi Nadahara, Masazumi Nishikawa, Akinori Ebe, Kenji Ishikawa, Osamu Oda, Masaru Hori
Publikováno v:
ACS Omega, Vol 5, Iss 41, Pp 26776-26785 (2020)
Externí odkaz:
https://doaj.org/article/245b6caa49c940b58b51a3d5470b652a
Autor:
Akira Horikoshi
Publikováno v:
Journal of Nihon University Medical Association. 80:243-245
Autor:
Osamu Oda, Takahiro Kimura, Kazuo Kinose, Shigeru Takatsuji, Masaru Hori, Soichi Nadahara, Akira Horikoshi, Masazumi Nishikawa, Kenji Ishikawa, Akinori Ebe, Atsushi Tanide, Shohei Nakamura
Publikováno v:
ACS Omega, Vol 5, Iss 41, Pp 26776-26785 (2020)
ACS Omega
ACS Omega
The growth of sputtered GaN at low temperature is strongly desired to realize the dissemination of low-cost GaN high electron mobility transistor devices for next-generation communication technology. In this work, the roles of atomic nitrogen (N)/hyd
Autor:
Akira Horikoshi, Hina Takano, Takashi Kumagai, Koiti Inokuchi, Junji Tanaka, Satoshi Morita, Masayuki Shiseki, Junichi Sakamoto, Naoki Takezako, Tetsuya Fukuda, Kaichi Nishiwaki, Chikashi Yoshida, Yasuji Kouzai, Akira Ohwada, Hisashi Sakamaki
Publikováno v:
International Journal of Clinical Oncology
Background With the introduction of imatinib, a first-generation tyrosine kinase inhibitor (TKI) to inhibit BCR-ABL1 kinase, the outcome of chronic-phase chronic myeloid leukemia (CP-CML) has improved dramatically. However, only a small proportion of
Autor:
Katsuhiro Miura, Yoshihito Uchino, Jin Takeuchi, Yoshimasa Kura, Masami Takei, Noriyoshi Iriyama, Satomi Kiso, Yukio Hirabayashi, Yoshihiro Hatta, Akira Horikoshi, Masahiko Sugitani, Machiko Kusuda, Umihiko Sawada, Hitomi Kodaira, Hiromichi Takahashi, Daisuke Kurita, Sumiko Kobayashi, Mai Yagi, Yujin Kobayashi, Masaru Nakagawa, Atsuko Hojo
Publikováno v:
Leukemia & Lymphoma. 55:2514-2519
We retrospectively evaluated the safety and efficacy of high-dose chemotherapy consisting of cyclophosphamide, etoposide and ranimustine (CEM) with autologous peripheral blood stem cell transplant (PBSCT) in 55 adult patients with relapsed or high-ri
Autor:
Shigeru Takatsuji, Makoto Sekine, Akira Horikoshi, Shohei Nakamura, Masaru Hori, Soichi Nadahara, Motohiro Kohno, Kazuo Kinose, Kenji Ishikawa, Atsushi Tanide
Publikováno v:
Journal of Vacuum Science & Technology B. 37:021209
Gallium nitride films were etched at 400 °C and 20 Pa with a radio-frequency-generated Cl2–BCl3 mixed plasma. While dog-legged profiles were obtained by plasma etching using pure Cl2, straight sidewall shapes were achieved through BCl3 gas additio
Autor:
Soichi Nadahara, Masazumi Nishikawa, Shigeru Takatsuji, Akira Horikoshi, Motohiro Kohno, Akinori Ebe, Kazuo Kinose, Masaru Hori, Shohei Nakamura, Atsushi Tanide, Kenji Ishikawa
Publikováno v:
Japanese Journal of Applied Physics. 58:SAAF04
Autor:
Hiroo Toyoda, Masami Takei, Jin Takeuchi, Bo Yuan, Shin Aizawa, Akira Horikoshi, Norio Takagi, Yuta Yoshino, Noriyoshi Iriyama, Yoshihiro Hatta
Publikováno v:
International Journal of Oncology. 44:865-873
The effects of all-trans retinoic acid (ATRA) and valproic acid (VPA), alone and in combination, on the human acute promyelocytic leukemia (APL) cell line NB4 were investigated in view of differentiation induction and growth inhibition. After 48 h of
Autor:
Yoshihiro Hatta, Jin Takeuchi, Yukio Hirabayashi, Noriyoshi Iriyama, Sumiko Kobayashi, Yoshihito Uchino, Yoshihiro Matsukawa, Katsuhiro Miura, Akira Horikoshi, Hitomi Kodaira, Hiromichi Takahashi
Publikováno v:
Chemotherapy. 59:152-158
Background: Elderly acute myeloid leukemia (AML) patients and patients with higher-risk myelodysplastic syndromes (MDS) have a much poorer prognosis than younger patients despite intensive chemotherapy. Methods: Ten patients with higher-risk MDS and
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 57(5)
Eltrombopag, a thrombopoietin (TPO) receptor agonist, is effective for treating refractory immune thrombocytopenia (ITP). However, the development of bone marrow fibrosis is a concern. A 78-year-old man was diagnosed with ITP in 2004. His platelet co